Cargando…
Long noncoding RNA amplified in lung cancer rewires cancer pathways
Athie et al. (2020. J. Cell Biol. https://doi.org/10.1083/jcb.201908078) identify ALAL-1, a lncRNA frequently amplified or overexpressed in lung cancer, as an oncogenic driver, capable of promoting the proliferation and altering the immunogenicity of lung cancer cells.
Autores principales: | Martínez-Terroba, Elena, Dimitrova, Nadya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480114/ https://www.ncbi.nlm.nih.gov/pubmed/32858749 http://dx.doi.org/10.1083/jcb.202007098 |
Ejemplares similares
-
Antiviral immunity rewired for axon regeneration
por: Jiang, Meng, et al.
Publicado: (2023) -
A mechanistic view of long noncoding RNAs in cancer
por: Winkler, Lauren, et al.
Publicado: (2021) -
Identification and characterization of functional long noncoding RNAs in cancer
por: Olivero, Christiane E., et al.
Publicado: (2020) -
The p53 transcriptional response across tumor types reveals core and senescence-specific signatures modulated by long noncoding RNAs
por: Tesfaye, Ephrath, et al.
Publicado: (2021) -
Neoadjuvant therapy gains FDA approval in non-small cell lung cancer
por: Leal, Ticiana A., et al.
Publicado: (2022)